An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer

NCT02140138 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
35
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for administrative reasons.

Conditions

Interventions

Sponsor

CureVac